AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Amlodipine, Valsartan, Hydrochlorothiazide in Rwanda
2 products registered with RDA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXFORGE HCT-5/160/12.5 | Rwanda FDA-HMP-MA-0089 | — | active | 5 Aug 2026 |
| EXFORGE HCT-10/160/12.5 | Rwanda FDA-HMP-MA-0092 | — | active | 5 Aug 2026 |
Amlodipine, Valsartan, Hydrochlorothiazide — RDA Registration Details
RDA (Rwanda) has 2 registered products containing Amlodipine, Valsartan, Hydrochlorothiazide, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Amlodipine, Valsartan, Hydrochlorothiazide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.